Internal Medicine, Infectious Disease · Greenwood, IN
NPI
1861474231
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
701 E County Line Rd, Suite 101
Greenwood, IN, 46143
Phone (317) 885-2860
Groups this clinician bills Medicare through
Medicare paid, 2024
$69K
1,000 services
Medicare patients, 2024
257
Average age 73
Drug cost, 2024
$601K
827 prescriptions
Company payments, 2025
$409
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David T Cox was code 99232 (hospital e&m - subsequent), 444 times for 131 patients. In total David T Cox billed 1,000 services in 28 codes, and Medicare paid $69K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 444 | 131 | $57.24 | $25K |
| 99233 Hospital E&M - Subsequent | Facility | 174 | 102 | $86.28 | $15K |
| 99222 Hospital E&M - Initial | Facility | 171 | 161 | $94.36 | $16K |
| 99214 Office E&M - Established | Office | 71 | 45 | $91.35 | $6,486 |
| 99213 Office E&M - Established | Office | 31 | 27 | $56.20 | $1,742 |
| 99204 Office E&M - New | Office | 11 | 11 | $123.16 | $1,355 |
By year: 2022 $57K for 940 services; 2023 $63K for 916 services; 2024 $69K for 1,000 services.
Medicare prescription drug claims, 2024
In 2024, the drug David T Cox prescribed most often to Medicare patients was Cephalexin, with 104 prescriptions and refills. In total David T Cox wrote 827 Medicare prescriptions that cost $601K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cephalexin Generic | 104 | 169 | 27 | $1,843 |
| Rifampin Generic | 67 | 80 | 12 | $5,662 |
| Azithromycin Generic | 62 | 71 | 11 | $1,304 |
| Ethambutol Hcl Generic | 55 | 63 | Under 11 | $4,640 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 49 | 63 | Under 11 | $416 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 40 | 40 | Under 11 | $156K |
| Doxycycline Hyclate Generic | 38 | 74 | 13 | $1,561 |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 35 | 35 | Under 11 | $37K |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 25 | 25 | Under 11 | $5,204 |
| Isentress Raltegravir Potassium | 24 | 24 | Under 11 | $48K |
| Ceftriaxone Ceftriaxone Sodium | 23 | 23 | Under 11 | $2,346 |
| Fluconazole Generic | 20 | 28 | Under 11 | $375 |
| Amoxicillin Generic | 17 | 27 | Under 11 | $90.7 |
| Daptomycin Generic | 16 | 16 | Under 11 | $61K |
| Lopinavir-Ritonavir Lopinavir/Ritonavir | 16 | 22 | Under 11 | $17K |
Brand drugs: 117 claims; generic drugs: 710 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David T Cox $409 ($409 in general payments such as food, travel and fees) from 8 companies. The largest payer was Abbvie Inc. with $166.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.